Compliance Policy Regarding Blood and Blood Component Donation Suitability, Donor Eligibility and Source Plasma Quarantine Hold Requirements: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 17, 2023
October 17, 2023
069f2c62-fbff-4ee9-af16-027d5e3e75a2
Related Documents
Compliance Policy Regarding Blood and Blood Component Donation Suitability, Donor Eligibility and Source Plasma Quarantine Hold Requirements: Guidance for Industry
Guidance DocumentOctober 14, 2026Center for Biologics Evaluation and Research
Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies: Guidance for Industry
Guidance DocumentOctober 19, 2023Center for Biologics Evaluation and Research
Blood Pressure and Pulse Donor Eligibility Requirements – Compliance Policy: Guidance for Industry
Guidance DocumentJuly 17, 2024Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.